Repeated spinal administration of the NFAT1‐specific inhibitor 11R‐VIVIT once daily on days 5, 6, and 7 post‐tumor inoculation (early‐phase treatment) significantly delayed the onset of mechanical allodynia (Figure 3A) and thermal hyperalgesia (Figure 3B). The gene discussed is NFATC2; the disease is neoplasm.